ClinicalTrials.Veeva

Menu

Determining The Impact Of Distance Reiki On Patient Reported QOL And Immunity Among Multiple Myeloma Patients

Mayo Clinic logo

Mayo Clinic

Status

Active, not recruiting

Conditions

Autologous Stem Cell Transplant
Multiple Myeloma

Treatments

Other: Distance Reiki
Other: Sham distance Reiki

Study type

Interventional

Funder types

Other

Identifiers

NCT04783038
NCI-2021-13433 (Other Grant/Funding Number)
20-007168

Details and patient eligibility

About

This research study is being done to determine if Distance Reiki therapy offers a quality of life benefit, and improves immunity compared to patients receiving Sham Distance Reiki therapy or no additional Reiki intervention.

Full description

Reiki is a popular complementary medicine modality sought after by patients. This non- intrusive Japanese based therapy centers on the guiding of energy through a Reiki practitioner to the patient which facilitates innate healing by modulation of energy fields. Reiki is formally classified as biofield therapy by the National Center for Complementary and Alternative Medicine (NCCAM).

Current research indicates that Reiki shows promise as a noninvasive healing tool for mind and body, particularly among patients with cancer. However, the data validating the effectiveness of Reiki integrated within a structured medical paradigm and the effect on cancer immunity remains unknown.

Given the clear demand for Reiki among cancer patients but skepticism within the medical community, this trial will aim to determine an objective patient reported quality of life (PRQoL) benefit by utilizing validated tools, in order to effectively implement Reiki into traditional medical practice.

Multiple myeloma patients are at high risk of serious illness from the COVID-19 virus during this pandemic, and so distance Reiki will be carried out via video conferencing platform.

Enrollment

30 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 18 years
  • Patients with Multiple Myeloma with stable disease or currently in maintenance therapy
  • English Speaking
  • Computer and internet access with video conferencing availability

Exclusion criteria

  • Evidence of disease relapse at the post-transplant follow up visit
  • Patient not returning to Mayo Clinic Rochester for subsequent post-transplant follow up

Trial design

Primary purpose

Supportive Care

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

30 participants in 3 patient groups

Distance Reiki
Active Comparator group
Description:
Subjects will be scheduled for once a week session of distance Reiki for 4 weeks.
Treatment:
Other: Distance Reiki
Sham Reiki
Sham Comparator group
Description:
Subjects will be scheduled for once a week session of Sham distance Reiki for 4 weeks.
Treatment:
Other: Sham distance Reiki
Standard of Care
No Intervention group
Description:
Subjects will not receive any Reiki treatment

Trial contacts and locations

1

Loading...

Central trial contact

Michelle Burtis

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems